On Wednesday, Shares of LendingClub Corp (NYSE:LC), gained 3.98% to $14.38.
Lending Club declared financial results for the second quarter ended June 30, 2015 and raised its outlook for the remainder of the year.
“We had another very strong quarter with accelerating revenue growth from 17% to 19% quarter over quarter and expanding margins from 13.1% in Q1 to 13.9% in Q2.” said Renaud Laplanche, CEO and founder. “Strong platform effects, industry leading position, superior engineering, and record high customer satisfaction translating into a loyal repeat customer base, have assisted us continue to lower our acquisition costs this quarter. These results and the continued momentum we are seeing give us the confidence to, once again, raise our outlook for the full year in terms of both growth and margins.”
LendingClub Corporation operates as an online marketplace for connecting borrowers and investors in the United States. Its marketplace facilitates various types of loan products for consumers and small businesses, counting unsecured personal loans, super prime consumer loans, unsecured education and patient finance loans, and unsecured small business loans.
Shares of VeriFone Systems Inc (NYSE:PAY), inclined 1.17% to $32.96, during its last trading session.
VeriFone Systems, will release its third quarter fiscal 2015 financial results after the market closes on September 3, 2015.
The administration of Verifone will host a webcast to review the financial results that day at 1:30 pm (PT).
VeriFone Systems, Inc. designs, markets, and services electronic payment solutions at the point of sale (POS) worldwide. It provides countertop electronic payment systems that accept card payment options, such as NFC, mobile wallets, chip and PIN, and contactless payments, in addition to support credit and debit card, EBT, EMV, and other PIN-based transactions; and a portfolio of application libraries and development tools.
Finally, Fibrocell Science Inc (NASDAQ:FCSC), ended its last trade with 12.48% gain, and closed at $7.48.
Fibrocell Science declared that David Pernock, Chairman and Chief Executive Officer, will present at the 2015 Wedbush PacGrow Healthcare Conference at 8:00 am EDT on Tuesday, August 11, 2015 in New York City.
Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company, through its proprietary autologous fibroblast technology, develops azficel-T, which is in Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring. It is also conducting orphan gene therapy program that is in pre-clinical development stage for the treatment of recessive dystrophic epidermolysis bullosa; and gene therapy program, which is in pre-clinical development stage for linear scleroderma.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
